Arrhythmias and Electrocardiogram pr prolongation

Summary:

Electrocardiogram pr prolongation is found among people with Arrhythmias, especially for people who are male, 60+ old.

The study analyzes which people have Electrocardiogram pr prolongation with Arrhythmias. It is created by eHealthMe based on reports of 20 people who have Arrhythmias from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Arrhythmias?

Arrhythmias (irregular heartbeat) is found to be associated with 2,760 drugs and 4,837 conditions by eHealthMe. Check the latest studies of Arrhythmias.

What is Electrocardiogram pr prolongation?

Electrocardiogram pr prolongation is found to be associated with 95 drugs and 207 conditions by eHealthMe. Check the latest studies of Electrocardiogram pr prolongation.



On Jul, 23, 2026

20 people who have Arrhythmias and Electrocardiogram Pr Prolongation are studied.

Would you have Electrocardiogram pr prolongation when you have Arrhythmias?

Gender of people who have Arrhythmias and experienced Electrocardiogram Pr Prolongation *:

  • female: 27.78 %
  • male: 72.22 %

Age of people who have Arrhythmias and experienced Electrocardiogram Pr Prolongation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 11.76 %
  • 20-29: 5.88 %
  • 30-39: 0.0 %
  • 40-49: 5.88 %
  • 50-59: 0.0 %
  • 60+: 76.47 %

Common co-existing conditions for these people *:

  1. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 30.00%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 25.00%
  3. Acute Myocardial Infarction (acute heart attack): 4 people, 20.00%
  4. High Blood Pressure: 3 people, 15.00%
  5. Ventricular Extrasystoles (premature cardiac contraction): 2 people, 10.00%

Common drugs taken by these people *:

  1. Aspirin: 12 people, 60.00%
  2. Clopidogrel: 6 people, 30.00%
  3. Eplerenone: 6 people, 30.00%
  4. Amiodarone Hydrochloride: 5 people, 25.00%
  5. Ticagrelor: 5 people, 25.00%
  6. Amlodipine: 5 people, 25.00%
  7. Pantoprazole: 5 people, 25.00%
  8. Metoprolol Succinate: 4 people, 20.00%
  9. Levothyroxine Sodium: 3 people, 15.00%
  10. Clopidogrel Bisulfate: 2 people, 10.00%

Common symptoms for these people *:

  1. Electrocardiogram Qt Prolonged: 8 people, 40.00%
  2. Atrial Tachycardia (rhythm disturbance that arises in the atria): 7 people, 35.00%
  3. Thyroid Diseases: 6 people, 30.00%
  4. Blood Thyroid Stimulating Hormone Increased: 6 people, 30.00%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 25.00%
  6. Drug Ineffective: 5 people, 25.00%
  7. Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 5 people, 25.00%
  8. Heart Rate Increased: 5 people, 25.00%
  9. Diastolic Dysfunction: 4 people, 20.00%
  10. Electrocardiogram P Wave Abnormal: 4 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Electrocardiogram pr prolongation?

- Check whether Electrocardiogram pr prolongation is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Electrocardiogram pr prolongation:

All the conditions that are associated with Electrocardiogram pr prolongation:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Electrocardiogram pr prolongation and Arrhythmias, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: